Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes
Potential for Combination Therapies Medications like tirzepatide combine GLP-1 and GIP agonism for enhanced metabolic benefits
2 Accordingly, the observed decline in male reproductive function is likely driven, at least in part, by the growing burden of chronic disease, including obesity and related comorbidities such as type 2 diabetes, which are increasingly linked to adverse reproductive and fertility outcomes
Thousands of Australians are starting GLP1 receptor agonist treatment each month, and the most common question new patients ask is simply: how do I actually use this pen
Diz-Chaves Y, Herrera-Prez S, Gonzlez-Matas LC, Lamas JA, Mallo F
Understanding why this happens and how to manage it can help you stay consistent with your weight loss plan and improve your quality of life while taking this powerful medication